Twist Bioscience's Chief Legal: What Investors Need to Know
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
Get paid for your opinions! Explore websites that reward you for sharing your thoughts and start earning today.
18,862 articlesA senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
Investors eye a steady $5,000 per month in dividends as a way to replace part of a paycheck. This report breaks down ...
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
IonQ stands out in the quantum race thanks to its accuracy edge. This article breaks down why ionq: quantum computing...
As Chewy released its latest earnings, investors faced mixed signals: growing revenue and better margins, but cautiou...
Gemini Space Station stock fell again this week, prompting questions beyond Bitcoin prices. This article breaks down ...
Great Elm's Q3 2026 earnings shed light on growth, margins, and capital allocation. This article breaks down the numb...
This guide dives into Arbe's Q2 2025 earnings, decoding revenue growth, margins, and guidance. Learn actionable ways ...
A new Nvidia platform called Vera Rubin could redefine AI economics for data centers. This piece breaks down what Ver...
With 2026's COLA at 2.8% and roughly 71 million Social Security beneficiaries, the decision on when to claim continue...
A high-stakes moment for semiconductor supply and AI chip strategy has investors watching ASML. This analysis explain...
NVIDIA just delivered spectacular quarterly results that surpassed expectations and reinforced its leadership in AI c...